KAT2B Antikörper
Kurzübersicht für KAT2B Antikörper (ABIN781338)
Target
Alle KAT2B Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Spezifität
- Nucleus
-
Aufreinigung
- Protein G-Sepharose affinity purified.
-
Immunogen
- Recombinant fragment of human KAT2B (C-terminus).
-
Isotyp
- IgG
-
-
-
-
Applikationshinweise
- Recommended dilutions. ELISA: 1/5000 - 1/20000. WB: 1/100-1/2000.
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Liquid
-
Konzentration
- 50µg/50µl
-
Buffer
- 0.02% Sodium Azide and 50% glycerol. 1% BSA, PBS, pH7.4.
-
Konservierungsmittel
- Sodium azide
-
Vorsichtsmaßnahmen
- This product contains sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
-
Lagerung
- -20 °C
-
-
- KAT2B (K(lysine) Acetyltransferase 2B (KAT2B))
-
Andere Bezeichnung
- KAT2B
-
Hintergrund
- CBP and p300 are large nuclear proteins that bind to many sequence-specific factors involved in cell growth and/or differentiation, including c-jun and the adenoviral oncoprotein E1A. The protein encoded by this gene associates with p300/CBP. It has in vitro and in vivo binding activity with CBP and p300, and competes with E1A for binding sites in p300/CBP.
-
Molekulargewicht
- 55kDa
-
NCBI Accession
- NM_003884
-
Pathways
- p53 Signalweg, Regulation of Carbohydrate Metabolic Process
Target
-